Synthetic VE (n = 12) | Natural VE (n = 13) | Placebo (n = 9) | Non-intervention (n = 10) | P-value | Adjusted p-value * | |
---|---|---|---|---|---|---|
DNA methylation (%) | ||||||
miR-9-1 | 8.7 ± 8.8 | 9.3 ± 10.6 | 12.8 ± 9.0 | 10.5 ± 9.2 | 0.637 | 1.000 |
miR-9-3 | 8.6 ± 7.7 | 2.8 ± 4.1 | 4.0 ± 4.1 | 5.7 ± 2.6 | 0.051 | 0.204 |
Age (years) | 42.1 ± 8.5 | 49.3 ± 7.7 | 46.7 ± 11.9 | 40.1 ± 6.7 | 0.062 | 0.248 |
Body mass index (kg/m2) | 29.9 ± 4.6 | 30.4 ± 3.8 | 30.0 ± 4.5 | 29.9 ± 3.6 | 0.918 | 1.000 |
Waist circumference (cm) | 90.9 ± 10.8 | 93.0 ± 7.4 | 92.3 ± 10.7 | 96.7 ± 7.7 | 0.518 | 1.000 |
Waist-to-height ratio (cm) | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.795 | 1.000 |
Family income ($) | 862.6 ± 317.2 | 1028.3 ± 652.0 | 1092.1 ± 1171.1 | 563.2 ± 447.6 | 0.155 | 0.620 |
Daily physical activity practice/min | 10.8 ± 25.4 | 23.1 ± 32.8 | 22.2 ± 27.3 | 10.0 ± 21.1 | 0.486 | 1.000 |
Proportion of active individuals n (%)a | 2(16.7) | 4(30.8) | 2(22.2) | 2(20.0) | 0.856 | 1.000 |
Proportion Peri and postmenopausal n (%)b | 5(41.7) | 9(69.2) | 6(66.7) | 6(60.0) | 0.517 | 1.000 |